Rosuvastatin Intermediates ZD9 CAS: 289042-10-0
Catalog Number | XD93415 |
Product Name | Rosuvastatin Intermediates ZD9 |
CAS | 289042-10-0 |
Molecular Formula | C28H29FN3O3PS |
Molecular Weight | 537.59 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Rosuvastatin Intermediates ZD9, also known as Z-4-(4-Fluorophenyl)-6-Isopropyl-2-[(N-Methyl-N-Methylsulfonyl)Amino]Pyrimidin-5-Yl, is a chemical compound that serves as an important intermediate in the synthesis of the cholesterol-lowering medication Rosuvastatin. This intermediate plays a vital role in the production of Rosuvastatin, which belongs to the class of drugs known as statins.ZD9 acts as a precursor compound in the multistep synthesis of Rosuvastatin. During the manufacturing process, ZD9 undergoes various chemical transformations to eventually yield the final product, Rosuvastatin. This synthesis involves the attachment of additional functional groups onto the ZD9 molecule, resulting in theformation of the active pharmaceutical ingredient, Rosuvastatin.Rosuvastatin is widely used for the treatment of hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood. It works by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in cholesterol synthesis in the body. By reducing the production of cholesterol, Rosuvastatin helps lower the overall cholesterol levels, including low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol.As an intermediate compound, ZD9 ensures that the synthesis of Rosuvastatin proceeds in a controlled and efficient manner. It acts as a building block that undergoes a series of chemical reactions, leading to the formation of specific bonds and functional groups necessary for Rosuvastatin's pharmacological activity.The synthesis of Rosuvastatin is a complex process, and each intermediate, including ZD9, is essential in ensuring the proper formation of the final product. Without ZD9, the synthesis of Rosuvastatin would not be possible, hindering the production of this important cholesterol-lowering medication.In summary, Rosuvastatin Intermediates ZD9 serves as a crucial intermediate in the synthesis of the widely used cholesterol-lowering medication, Rosuvastatin. It acts as a building block that undergoes chemical transformations to ultimately yield the active pharmaceutical ingredient. By playing a vital role in the production process, ZD9 contributes to the availability of an important medication for the treatment of high cholesterol levels in patients.